Health Condition 1: K053- Chronic periodontitis
Conditions
Interventions
Intervention1: T-PRF Membrane: Full thickness mucoperiosteal flap will be raised followed by placement of T-PRF membrane and bioactive calcium phosphosilicate bonegraft(Novabone putty and Novabone Mor
Sponsors
Dr Lekshmi R
Eligibility
Inclusion criteria
Inclusion criteria: Patients diagnosed with generalised chronic periodontitis. Patients willing to take part in the study. Systemically healthy patients. Presence of 2-3 wall intrabony defects with = 3mm (the distance between the alveolar crest and base of defect) on intraoral periapical radiograph [IOPA] along with interproximal probing depth[PD] = 5mm after phase 1 therapy. Patients with no history of allergy to materials and drugs used or prescribed in this study.
Exclusion criteria
Exclusion criteria: Patients who have undergone periodontal treatment within a period of 1 year. Patients on any medication taken within the last 6 months which may alter the periodontal status. Chronic smokers and alcoholics. Pregnant and lactating females
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To clinically evaluate Probing Pocket depth (PPD),Clinical attachment level (CAL),Thickness of attached gingiva and radiographically (IOPAR or RVG) to evaluate and to measure the intrabony defect (the distance between the alveolar crest and base of defect) Timepoint: at baseline and after 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| To evaluate clinically and radiographically the regenerative potential of T-PRF and xenogenic collagen membrane in conjunction with bioactive calcium phosphosilicate bonegraft (Novabone putty and Novabone Morsels) in the treatment of periodontal intrabony defects.Timepoint: 6 months | — |
Countries
India
Contacts
Public ContactDR KRISHNA KRIPAL
Rajarajeswari dental college and hospital
Outcome results
None listed